# 2025-01710: DEA OKs Noramco to Bulk-Produce Marijuana and Painkillers

2025-01710, Bulk Manufacturer of Controlled Substances Application: Noramco, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2025-01-24, effective Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before March 25, 2025. Such persons may also file a written request for a hearing on the application on or before March 25, 2025. (as of 2026-09-21).

- Canonical: https://policyrisk.com/federal-register/2025-01710
- As of: 2026-09-21
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-01710
- Title: Bulk Manufacturer of Controlled Substances Application: Noramco
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: unknown
- Published: 2025-01-24
- Effective: Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before March 25, 2025. Such persons may also file a written request for a hearing on the application on or before March 25, 2025.
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-09-21

## In one line

DEA OKs Noramco to Bulk-Produce Marijuana and Painkillers

## Summary

Noramco wants to become a big-time maker of certain controlled drugs, including marijuana and some painkillers. If you’re a current manufacturer or interested party, you can share your thoughts or ask for a hearing by March 25, 2025. This move could shake up who supplies these substances, but no direct costs or changes for the public are expected right now.

## Abstract

Noramco has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2025-01710 on federalregister.gov](https://www.federalregister.gov/documents/2025/01/24/2025-01710/bulk-manufacturer-of-controlled-substances-application-noramco)
- [2025-01710 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-01-24/pdf/2025-01710.pdf)

## Related
- [Previous: 2025-01709, Advisory Committee on Appellate Rules; Meeting of the Judicial Conference](https://policyrisk.com/federal-register/2025-01709)
- [Next: 2025-01711, Bulk Manufacturer of Controlled Substances Application: Veranova, L.P.](https://policyrisk.com/federal-register/2025-01711)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-01710 (as of 2026-09-21).
